Treatment agent for polyester staple fiber spunlace, dilution of treatment agent for polyester staple fiber spunlace, first treatment agent for polyester staple fiber spunlace, second treatment agent for polyester staple fiber spunlace, and polyester staple fiber

A treatment agent for polyester short fibers, containing fatty acid derivatives and organic phosphate ester salts, addresses the need for improved antistatic properties and uniformity, enhancing the quality of spunlace nonwoven fabrics by reducing static and improving web uniformity.

JP7580861B1Active Publication Date: 2024-11-12TAKEMOTO OIL & FAT CO LTD

Patent Information

Application Number
JP2024084649
Authority / Receiving Office
JP · JP
Patent Type
Patents
Current Assignee / Owner
Filing Date
2024-05-24
Publication Date
2024-11-12
Estimated Expiration
2044-05-24

AI Technical Summary

Technical Problem

Polyester short fibers require improved antistatic properties and uniformity in the roller carded web during the carding process to enhance the quality of spunlace nonwoven fabrics.

Method used

A treatment agent for polyester short fibers comprising specific fatty acid derivatives, organic phosphate ester salts, and optionally diesters is applied, with precise mass proportions to improve antistatic properties and uniformity.

Benefits of technology

The treatment agent enhances antistatic properties, improves uniformity of the roller card web, and suppresses foaming during the spunlace process, resulting in higher-quality nonwoven fabrics.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure 0007580861000001
    Figure 0007580861000001
  • Figure 0007580861000002
    Figure 0007580861000002
  • Figure 0007580861000003
    Figure 0007580861000003
Patent Text Reader

Abstract

Improves the antistatic properties and roller card web uniformity of polyester staple fibers treated with a treatment agent for polyester staple fiber spunlace. The treating agent for polyester staple fiber spunlace contains the following fatty acid derivative (A), the following fatty acid derivative (B), and an organic phosphate ester salt (C). Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): at least one alkylene oxide adduct selected from oleic acid and stearic acid.
Need to check novelty before this filing date? Find Prior Art

Description

[Technical field]

[0001] The present invention relates to a treating agent for polyester staple spunlace fibers, a diluted solution of a treating agent for polyester staple spunlace fibers, a first treating agent for polyester staple spunlace fibers, a second treating agent for polyester staple spunlace fibers, and polyester staple fibers. [Background technology]

[0002] For example, a fiber treatment agent may be applied to the surface of a synthetic fiber during a spinning process, drawing process, finishing process, etc. In addition, a roller-carded web of synthetic fibers is generally produced by a carding process using a roller card, and then the fibers constituting the roller-carded web are entangled by a spunlace process to produce a nonwoven fabric.

[0003] For example, Patent Document 1 describes a treatment agent for producing nonwoven fabrics for spunlace that contains a fatty acid having 4 to 11 carbon atoms, an organic phosphate ester, a nonionic surfactant, etc. It describes that the use of the treatment agent for producing nonwoven fabrics provides excellent entanglement and scum suppression, and reduces foaming during the spunlace process.

[0004] Patent Document 2 describes a fiber treatment agent for spunlace nonwoven fabric production that contains an ester compound of a dibasic acid and a diol, and an alkyl phosphate ester. It describes that the use of the fiber treatment agent for spunlace nonwoven fabric production can impart excellent smoothness and softness to fibers, and can also suppress foaming during the spunlace process. [Prior art documents] [Patent documents]

[0005] [Patent Document 1] Patent No. 6605833 [Patent Document 2] Patent No. 4139130 Summary of the Invention [Problem to be solved by the invention]

[0006] Meanwhile, polyester staple fibers to which a fiber-treating agent has been applied are required to have improved antistatic properties and improved uniformity of the roller carded web obtained in the carding process. [Means for solving the problem]

[0007] As a result of research aimed at solving the above problems, the present inventors have found that a polyester staple fiber treating agent containing a specific fatty acid derivative and an organic phosphate ester salt is precisely suitable.

[0008] Various aspects for solving the above problems will be described below. The treating agent for polyester staple fiber spunlace of embodiment 1 is characterized in that it contains the following fatty acid derivative (A), the following fatty acid derivative (B), and an organic phosphoric acid ester salt (C). The treatment agent for polyester staple fiber spunlace contains, in the non-volatile content of the treatment agent for polyester staple fiber spunlace, the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25% by mass or more and 90% by mass or less, and the organic phosphate ester salt (C) in a proportion of 5% by mass or more and 65% by mass or less.

[0009] Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): at least one alkylene oxide adduct selected from oleic acid and stearic acid.

[0010] In a second aspect, in the treating agent for polyester staple fiber spunlace according to the first aspect, the mass proportion of oxyalkylene groups in the molecular structures of the fatty acid derivative (A) and the fatty acid derivative (B) is 50 mass % or less, respectively.

[0011] In aspect 3, in the treatment agent for polyester staple fiber spunlace according to aspect 1 or 2, when the mass of the fatty acid derivative (A) in the treatment agent for polyester staple fiber spunlace is Am and the mass of the fatty acid derivative (B) in the treatment agent for polyester staple fiber spunlace is Bm, the mass ratio Am / Bm is 0.01 or more and 0.4 or less.

[0012] In a fourth aspect, in the treating agent for polyester staple fiber spunlace according to any one of the first to third aspects, the organic phosphate salt (C) is a salt of a phosphate ester having an alkyl group having 11 to 13 carbon atoms.

[0013] Aspect 5 is the treating agent for polyester staple fiber spunlace according to any one of Aspects 1 to 4, wherein the non-volatile content of the treating agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 30% by mass or more and 70% by mass or less, and the organic phosphate ester salt (C) in a proportion of 10% by mass or more and 60% by mass or less.

[0014] A sixth aspect is the treating agent for polyester staple fiber spunlace according to any one of the first to fifth aspects, further comprising the following diester (D). Diester (D): A diester of polyethylene glycol having a molecular weight of 200 or more and 800 or less and a monovalent fatty acid having 12 or more and 20 or less carbon atoms.

[0015] Aspect 7 is the treating agent for polyester staple fiber spunlace according to Aspect 6, wherein the non-volatile content of the treating agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 30% by mass or more and 70% by mass or less, the organic phosphate ester salt (C) in an amount of 10% by mass or more and 60% by mass or less, and the diester (D) in an amount of 2% by mass or more and 10% by mass or less.

[0016] A dilute solution of a treatment agent for polyester staple fiber spunlace of an eighth aspect is characterized in that it contains the treatment agent for polyester staple fiber spunlace of any one of the first to seventh aspects, and water.

[0017] The first treatment agent for polyester staple fiber spunlace of embodiment 9 is used in combination with a second treatment agent for polyester staple fiber spunlace containing an organic phosphate ester salt (C), and contains the following fatty acid derivative (A), the following fatty acid derivative (B), and optionally the following diester (D). In addition, the first treatment agent for polyester staple fiber spunlace is used in combination with the second treatment agent for polyester staple fiber spunlace so that the non-volatile content of the treatment agent for polyester staple fiber spunlace mixed with the second treatment agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25% by mass or more and 90% by mass or less, and the organic phosphate ester salt (C) in a proportion of 5% by mass or more and 65% by mass or less.

[0018] Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): at least one alkylene oxide adduct selected from oleic acid and stearic acid.

[0019] Diester (D): A diester of polyethylene glycol having a molecular weight of 200 or more and 800 or less and a monovalent fatty acid having 12 or more and 20 or less carbon atoms. The second treatment agent for polyester staple fiber spunlace of embodiment 10 is used in combination with a first treatment agent for polyester staple fiber spunlace containing the following fatty acid derivative (A), the following fatty acid derivative (B), and optionally the following diester (D), and contains an organic phosphate ester salt (C). In addition, the second treatment agent for polyester staple fiber spunlace is used in combination with the first treatment agent for polyester staple fiber spunlace so that the non-volatile content of the treatment agent for polyester staple fiber spunlace mixed with the first treatment agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25% by mass or more and 90% by mass or less, and the organic phosphate ester salt (C) in a proportion of 5% by mass or more and 65% by mass or less.

[0020] Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): at least one alkylene oxide adduct selected from oleic acid and stearic acid.

[0021] Diester (D): A diester of polyethylene glycol having a molecular weight of 200 to 800 and a monovalent fatty acid having 12 to 20 carbon atoms. The polyester staple fiber of an eleventh aspect is characterized in that the treating agent for polyester staple fiber spunlace according to any one of the first to seventh aspects is adhered to the polyester staple fiber. Effect of the Invention

[0022] According to the present invention, the polyester staple fibers to which the treatment agent for polyester staple fiber spunlace has been applied can have improved antistatic properties and uniformity of a roller card web. DETAILED DESCRIPTION OF THE PREFERRED EMBODIMENTS

[0023] First Embodiment Hereinafter, a first embodiment of the treatment agent for polyester staple fiber spunlace (hereinafter, simply referred to as the treatment agent) of the present invention will be described. The treatment agent of this embodiment contains the following fatty acid derivative (A), the following fatty acid derivative (B), and an organic phosphoric acid ester salt (C).

[0024] (Fatty acid derivative (A)) The fatty acid derivative (A) is an alkylene oxide adduct of at least one acid selected from linoleic acid and linolenic acid.

[0025] The alkylene oxide preferably has a carbon number of 2 or more and 4 or less, and more preferably has a carbon number of 2 or 3. Specific examples of the alkylene oxide having a carbon number of 2 or more and 4 or less include ethylene oxide (hereinafter also referred to as EO), propylene oxide (hereinafter also referred to as PO), butylene oxide, etc.

[0026] The number of moles of alkylene oxide added is not particularly limited, but is preferably 0.1 moles or more and 20 moles or less, more preferably 0.5 moles or more and 18 moles or less, and even more preferably 0.5 moles or more and 15 moles or less.

[0027] The number of moles of alkylene oxide added may be any range that combines the above upper and lower limits. The number of moles of alkylene oxide added indicates the number of moles of alkylene oxide per mole of the compound to be added in the raw material. The alkylene oxide may be one type of alkylene oxide used alone, or two or more types of alkylene oxides may be used in appropriate combination. When two or more types of alkylene oxides are used, the addition form may be any of block addition, random addition, and a combination of block addition and random addition, and is not particularly limited.

[0028] The fatty acid derivative (A) may be a dicarboxylic acid in which linoleic acid or linolenic acid is bonded to both ends of an alkylene oxide, or a monocarboxylic acid in which linoleic acid or linolenic acid is bonded to one end of an alkylene oxide. The fatty acid derivative (A) is preferably a monocarboxylic acid.

[0029] The mass ratio of the oxyalkylene group in the molecular structure of the fatty acid derivative (A) is preferably 50 mass% or less. When the mass ratio of the oxyalkylene group in the molecular structure of the fatty acid derivative (A) is 50 mass% or less, foaming of the water stream can be easily suppressed when the high-pressure water stream is sprayed in the spunlace process. In other words, the foaming suppression property can be improved.

[0030] (Fatty acid derivative (B)) The fatty acid derivative (B) is an adduct of at least one alkylene oxide selected from oleic acid and stearic acid.

[0031] The alkylene oxide may be the same as the alkylene oxide in the fatty acid derivative (A). The fatty acid derivative (B) may be a dicarboxylic acid in which oleic acid or stearic acid is bonded to both ends of an alkylene oxide, or a monocarboxylic acid in which oleic acid or stearic acid is bonded to one end of an alkylene oxide. The fatty acid derivative (B) is preferably a monocarboxylic acid. However, the fatty acid derivative (B) does not include the diester (D) described later.

[0032] The mass ratio of oxyalkylene groups in the molecular structure of the fatty acid derivative (B) is preferably 50 mass% or less. When the mass ratio of oxyalkylene groups in the molecular structure of the fatty acid derivative (B) is 50 mass% or less, the foaming suppression property can be improved when a high-pressure water stream is sprayed in the spunlace process.

[0033] It is more preferable that the mass ratio of the oxyalkylene group in the molecular structure of each of the fatty acid derivatives (A) and (B) is 50 mass% or less. When the mass ratio of the oxyalkylene group in the molecular structure of each of the fatty acid derivatives (A) and (B) is 50 mass% or less, the foam suppressing property can be further improved.

[0034] The mass proportion of oxyalkylene groups in the molecular structure of either the fatty acid derivative (A) or the fatty acid derivative (B) may be 50 mass % or less. (Organophosphate ester salts (C)) Examples of the organic phosphate salt (C) include salts of alkyl phosphate esters, alkenyl phosphate esters, etc. The alkyl group or alkenyl group constituting the alkyl phosphate ester is not particularly limited, and may be, for example, linear or branched.

[0035] Alcohols that can be used as raw materials for the organic phosphate salt (C) include monohydric aliphatic alcohols. Specific examples of monohydric aliphatic alcohols include (1) linear alkyl alcohols such as methanol, ethanol, propanol, butanol, pentanol, hexanol, octanol, nonanol, decanol, undecanol, dodecanol, tridecanol, tetradecanol, pentadecanol, hexadecanol, heptadecanol, octadecanol, nonadecanol, eicosanol, heneicosanol, docosanol, tricosanol, tetracosanol, pentacosanol, hexacosanol, heptacosanol, octacosanol, nonacosanol, and triacontanol; (2) isopropanol, isobutanol, isohexanol, 2-ethylhexanol, isononanol, isodecanol, isododecanol, isotridecanol, and isotetradecanol. (3) branched alkyl alcohols such as tetradecenol, isopentadecanol, isohexadecanol, isoheptadecanol, isooctadecanol, isonadecanol, isoeicosanol, isoheneicosanol, isodocosanol, isotricosanol, isotetracosanol, 2-decyltetradecanol, isopentacosanol, isohexacosanol, isoheptacosanol, isooctacosanol, isononacosanol, and isotriacontanol; (4) linear alkenyl alcohols such as tetradecenol, hexadecenol, heptadecenol, octadecenol, oleyl alcohol, and nonadecenol; (5) branched alkenyl alcohols such as isohexadecenol and isooctadecenol; and (6) cyclic alkyl alcohols such as cyclopentanol and cyclohexanol.

[0036] The phosphoric acid constituting the organic phosphate ester salt (C) is not particularly limited, and may be orthophosphoric acid or a polyphosphoric acid such as diphosphoric acid. Examples of the organic phosphate salt (C) include amine phosphate salts and metal phosphate salts.

[0037] The amine constituting the amine salt may be any of a primary amine, a secondary amine, and a tertiary amine. Specific examples of amines constituting the amine salts include, for example, (1) aliphatic amines such as methylamine, dimethylamine, trimethylamine, ethylamine, diethylamine, triethylamine, N-diisopropylethylamine, butylamine, dibutylamine, 2-methylbutylamine, tributylamine, octylamine, and dimethyllaurylamine; (2) aromatic amines or heterocyclic amines such as aniline, N-methylbenzylamine, pyridine, morpholine, piperazine, and derivatives thereof; (3) alkanolamines such as monoethanolamine, N-methylethanolamine, diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, triisopropanolamine, dibutylethanolamine, butyldiethanolamine, octyldiethanolamine, and lauryldiethanolamine; (4) arylamines such as N-methylbenzylamine; (5) polyoxyalkylene alkylamino ethers such as polyoxyethylene lauryl amino ether and polyoxyethylene steryl amino ether; and (6) ammonia.

[0038] Examples of metal salts include alkali metal salts and alkaline earth metal salts. Specific examples of alkali metals constituting alkali metal salts include sodium, potassium, lithium, etc. Examples of alkaline earth metals constituting alkaline earth metal salts include metals belonging to Group 2 elements, such as calcium, magnesium, beryllium, strontium, barium, etc.

[0039] Specific examples of the organic phosphate salt (C) include undecyl phosphate potassium salt, dodecyl phosphate potassium salt, tridecyl phosphate potassium salt, dodecyl phosphate sodium salt, octadecyl phosphate potassium salt, and octyl phosphate potassium salt.

[0040] The organic phosphate salt (C) is preferably a salt of a phosphate ester of an aliphatic alcohol having 11 to 13 carbon atoms. In other words, the organic phosphate salt (C) is preferably a salt of a phosphate ester having an alkyl group having 11 to 13 carbon atoms. When the organic phosphate salt (C) is a salt of a phosphate ester having an alkyl group having 11 to 13 carbon atoms, the antistatic properties of the polyester staple fibers can be further improved.

[0041] As for these organic phosphate ester salts (C), one type of organic phosphate ester salt (C) may be used alone, or two or more types of organic phosphate ester salts (C) may be used in appropriate combination.

[0042] The acid value of the organic phosphate salt (C) is appropriately set, but is preferably 5 to 100 KOH-mg / g, and more preferably 10 to 80 KOH-mg / g. The acid value of the organic phosphate ester salt (C) is calculated from the following formula by dissolving the organic phosphate ester salt (C) in a mixed solvent of ethanol / xylene = 1 / 2 (volume ratio), setting it in a potentiometric titrator, and titrating it with a 0.1 mol / L standard solution of potassium hydroxide in methanol.

[0043] Acid value (KOH-mg / g)=(R×f×56.11×0.1) / S In the formula, f: Factor of 0.1 mol / L potassium hydroxide methanol standard solution S: Sample amount (g, solid content equivalent) R: Amount of 0.1 mol / L potassium hydroxide methanol standard solution used up to the inflection point (mL) (Content) When the mass of the fatty acid derivative (A) in the treatment agent is Am and the mass of the fatty acid derivative (B) is Bm, the mass ratio Am / Bm is preferably 0.01 or more and 0.4 or less.

[0044] When the value of the mass ratio Am / Bm is within the above numerical range, the uniformity of the roller carded web of polyester staple fibers (hereinafter also referred to as roller carded web uniformity) can be further improved.

[0045] The roller card web uniformity means the property of obtaining a web that is free from disturbances in web texture and has a good appearance when a web is produced by a roller carding process using polyester staple fibers to which a treatment agent has been applied.

[0046] The non-volatile content of the treatment agent preferably contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 30% by mass or more and 70% by mass or less, and the organic phosphate ester salt (C) in a proportion of 10% by mass or more and 60% by mass or less.

[0047] When the contents of the fatty acid derivative (A), the fatty acid derivative (B), and the organic phosphate salt (C) are within the above numerical ranges, all of the antistatic property, antifoam property, and hydrophilicity can be improved. In the non-volatile content of the treatment agent, the total of the fatty acid derivative (A), the fatty acid derivative (B), and the organic phosphate ester salt (C) does not necessarily have to be 100% by mass. For example, as described below, the treatment agent may contain a diester (D) or other components (E).

[0048] The non-volatile content of the treatment agent refers to the residue after the treatment agent is heat-treated at 105°C for 2 hours. The same applies below. The treatment agent may further contain the following diester (D).

[0049] (Diester (D)) The diester (D) is a diester of polyethylene glycol having a molecular weight of 200 or more and 800 or less and a monovalent fatty acid having 12 or more and 20 or less carbon atoms.

[0050] By including the diester (D) in the treatment agent, the hydrophilicity of the polyester staple fibers and the uniformity of the roller card web can be further improved. The above molecular weight means the weight average molecular weight.

[0051] Examples of monovalent fatty acids having 12 to 20 carbon atoms include dodecanoic acid (lauric acid), tridecanoic acid, tetradecanoic acid (myristic acid), pentadecanoic acid, hexadecanoic acid (palmitic acid), heptadecanoic acid, octadecanoic acid (stearic acid), nonadecanoic acid, and icosanoic acid.

[0052] Specific examples of the diester (D) include a diester of polyethylene glycol having a mass average molecular weight of 200 and oleic acid (hereinafter also referred to as polyoxyethylene (mass average molecular weight 200) dioleate), a diester of polyethylene glycol having a mass average molecular weight of 800 and oleic acid (hereinafter also referred to as polyoxyethylene (mass average molecular weight 800) dioleate), a diester of polyethylene glycol having a mass average molecular weight of 400 and lauric acid (hereinafter also referred to as polyoxyethylene (mass average molecular weight 400) dilaurate), and a diester of polyethylene glycol having a mass average molecular weight of 600 and lauric acid (hereinafter also referred to as polyoxyethylene (mass average molecular weight 600) dilaurate).

[0053] Regarding these diesters (D), one type of diester (D) may be used alone, or two or more types of diesters (D) may be used in appropriate combination. The method for measuring the weight average molecular weight of the diester (D) is not limited, and any known method can be used, for example, gel permeation chromatography.

[0054] (Content) The non-volatile content of the treatment agent preferably contains a total of 30% by mass or more and 70% by mass or less of the fatty acid derivative (A) and the fatty acid derivative (B), 10% by mass or more and 60% by mass or less of the organic phosphate ester salt (C), and 2% by mass or more and 10% by mass or less of the diester (D).

[0055] In the non-volatile content of the treatment agent, the total of the fatty acid derivative (A), the fatty acid derivative (B), the organic phosphoric acid ester salt (C), and the diester (D) does not necessarily have to be 100% by mass. For example, as described later, the treatment agent may contain another component (E).

[0056] When the contents of the fatty acid derivative (A), the fatty acid derivative (B), the organic phosphate salt (C), and the diester (D) are within the above numerical ranges, the roller card web uniformity of the polyester staple fibers and the emulsion stability of the treatment agent can be further improved.

[0057] (Other ingredients (E)) The treatment agent of this embodiment may contain other components (E). Examples of other components (E) include components that are usually used in treatment agents, such as stabilizers, antistatic agents, binders, antioxidants, ultraviolet absorbers, surfactants, pH adjusters, and higher alcohols. Examples of surfactants include nonionic surfactants. Note that higher alcohols refer to monohydric alcohols having 6 or more carbon atoms.

[0058] Specific examples of the other component (E) include a compound in which 9 moles of EO and 9 moles of PO are randomly added to 1 mole of castor oil, a compound in which 7 moles of EO and 3 moles of PO are randomly added to 1 mole of castor oil, a compound in which 5 moles of EO and 5 moles of PO are randomly added to 1 mole of hydrogenated castor oil, a compound in which 9 moles of EO and 9 moles of PO are randomly added to 1 mole of hydrogenated castor oil, sodium salt of secondary alkanesulfonic acid having 11 to 14 carbon atoms, lauryl alcohol, oleic acid, potassium salt of octanoic acid, an ester compound obtained by dehydration condensation of 0.1 mole of polyoxyethylene polyoxypropylene glycol (random polymer: mass average molecular weight 13,000, EO component ratio 75% by mass), 0.5 moles of polyethylene glycol (mass average molecular weight 600), and 0.4 moles of polyethylene glycol (mass average molecular weight 400) to 1 mole of sebacic acid, propylene glycol, potassium salt of ethylene glycol monobutyl ether phosphate, and polyoxyethylene (mass average molecular weight 400) monolaurate.

[0059] The other components (E) may be used alone or in combination of two or more kinds of the other components (E). In other words, the other components (E) may contain at least one of the above.

[0060] The content of the other component (E) is not particularly limited, and it can be contained within a range that does not impair the effects of the present invention. In the non-volatile content of the treatment agent, the content of the other component (E) can be, for example, 60% by mass or less, 50% by mass or less, 40% by mass or less, 30% by mass or less, 20% by mass or less, 10% by mass or less, or 0% by mass. It can also be 5% by mass or more, or 10% by mass or more. The content of the other component (E) can be within any range that combines the above upper and lower limits.

[0061] (Preservation form) The treatment agent may be configured as a one-component type containing the above-mentioned fatty acid derivative (A), fatty acid derivative (B), and organic phosphate ester salt (C), or from the viewpoint of improving formulation stability and storage stability, it may be configured as a two-component type treatment agent as shown below.

[0062] The two-component type treatment agent is configured as a set including a first treatment agent (hereinafter also referred to as the first treatment agent) for polyester staple fiber spunlace containing a fatty acid derivative (A), a fatty acid derivative (B), and optionally a diester (D), and a second treatment agent (hereinafter also referred to as the second treatment agent) for polyester staple fiber spunlace containing an organic phosphate ester salt (C). The other component (E) may be contained in either or both of the first treatment agent and the second treatment agent.

[0063] A two-component type treatment agent is composed of a first treatment agent and a second treatment agent constituted as a separate agent from the first treatment agent during storage or distribution, etc. When used, the two-component type treatment agent is prepared by mixing the first treatment agent and the second treatment agent.

[0064] (solvent) The treatment agent of the first embodiment can be mixed with a solvent as necessary to prepare a composition containing a treatment agent for polyester staple fiber spunlace, or a diluted solution of the treatment agent for polyester staple fiber spunlace, and the composition can be stored or distributed in the form of a composition containing a treatment agent for polyester staple fiber spunlace.

[0065] The solvent has a boiling point of 105° C. or less at one atmospheric pressure. Examples of the solvent include water and organic solvents. Specific examples of water include ion-exchanged water, distilled water, hard water, soft water, etc. Specific examples of the organic solvent include low-polarity solvents such as lower alcohols such as ethanol and propanol, and hexane. These solvents may be used alone or in appropriate combination of two or more solvents. Among these, polar solvents such as water and lower alcohols are preferred from the viewpoint of excellent dispersibility or solubility of each component, and water is more preferred from the viewpoint of excellent handling.

[0066] <Actions and Effects of the First Embodiment> (1-1) The treatment agent of the first embodiment contains the fatty acid derivative (A), the fatty acid derivative (B), and the organic phosphoric acid ester salt (C) described above, and therefore can improve the antistatic properties of the polyester staple fiber to which the treatment agent is applied and the uniformity of the roller carded web.

[0067] (1-2) Furthermore, by containing the above-mentioned diester (D), the hydrophilicity of the polyester staple fibers to which the treatment agent has been applied and the uniformity of the roller card web can be further improved.

[0068] <Second embodiment> Next, a second embodiment of the diluted solution of a treatment agent for polyester staple fiber spunlace (hereinafter, simply referred to as the diluted solution) of the present invention will be described. The following mainly describes the differences from the first embodiment.

[0069] The dilution liquid of the present embodiment contains the treatment agent and water. The dilution liquid is used as an emulsion by mixing the treatment agent with water. Specific examples of water include ion-exchanged water, distilled water, hard water, soft water, etc. Among these, it is preferable to use ion-exchanged water and distilled water.

[0070] The method for preparing the dilution solution is not particularly limited, and for example, a method of adding a predetermined amount of the treatment agent to a previously measured amount of water can be mentioned. Furthermore, the dilution solution can be prepared by a known mechanical emulsification method using a known homomixer, homogenizer, or the like.

[0071] The diluent may contain a known solvent other than water, such as the organic solvents described above. The concentration of the treatment agent in the diluted solution is not particularly limited. The concentration of the treatment agent can be, for example, 30% by mass or more, 40% by mass or more, 50% by mass or more, or 60% by mass or more. It can also be 95% by mass or less, 90% by mass or less, 80% by mass or less, or 70% by mass or less. The concentration of the treatment agent can be any range that combines the above upper and lower limits.

[0072] <Actions and Effects of the Second Embodiment> In addition to the actions and effects of the first embodiment, the second embodiment has the following actions and effects.

[0073] (2-1) The dilution liquid of the second embodiment contains the above-mentioned treatment agent and water. Therefore, the treatment agent can be applied to the polyester staple fibers in the form of an emulsion. In addition, the dilution liquid is easy to handle by containing water as a solvent.

[0074] <Third embodiment> Next, a third embodiment of the first treatment agent for polyester staple fiber spunlace (first treatment agent) of the present invention will be described. The following mainly describes the differences from the first embodiment. The first treatment agent contains a fatty acid derivative (A), a fatty acid derivative (B), and optionally a diester (D).

[0075] The first treatment agent is used in combination with a second treatment agent for polyester staple fiber spunlace (hereinafter, simply referred to as the second treatment agent) containing an organic phosphate ester salt (C). That is, when used, the first treatment agent and the second treatment agent are mixed to prepare a mixture as a treatment agent.

[0076] The fatty acid derivative (A), the fatty acid derivative (B), the organic phosphoric acid ester salt (C), and the diester (D) are the same as the components described in the first embodiment. The first treatment agent may contain the above-mentioned other component (E).

[0077] (solvent) The first treatment agent of the third embodiment is mixed with a solvent as necessary to prepare a diluted first treatment agent for polyester staple fiber spunlace (hereinafter also referred to as a diluted first treatment agent). The first treatment agent may be stored or distributed in the form of a diluted first treatment agent. With this configuration, when the first treatment agent is diluted with a solvent or mixed with the second treatment agent at the time of use, the mixability is improved and the stability of the composition is improved. The solvent may be one exemplified in the first embodiment.

[0078] <Actions and Effects of the Third Embodiment> In addition to the actions and effects of the first and second embodiments, the third embodiment has the following actions and effects.

[0079] (3-1) The first treatment agent of the third embodiment contains a fatty acid derivative (A), a fatty acid derivative (B), and optionally a diester (D), and is used in combination with a second treatment agent containing an organic phosphoric acid ester salt (C) during use. Therefore, the formulation stability and storage stability of the first treatment agent can be improved during storage or distribution. In addition, the components of the resulting treatment agent can be adjusted by adjusting the mixing ratio with the second treatment agent. In addition, the first treatment agent alone can be distributed as a separate agent from the second treatment agent.

[0080] <Fourth embodiment> Next, a fourth embodiment of the second treatment agent (second treatment agent) for polyester staple fiber spunlace of the present invention will be described. The following mainly describes the differences from the first to third embodiments. The second treatment agent contains an organic phosphate ester salt (C). The second treatment agent is used in combination with a first treatment agent containing a fatty acid derivative (A), a fatty acid derivative (B), and optionally a diester (D). That is, when used, a mixture of the first treatment agent and the second treatment agent is prepared as a treatment agent.

[0081] The fatty acid derivative (A), the fatty acid derivative (B), the organic phosphoric acid ester salt (C), and the diester (D) are the same as those described in the first embodiment. The second treatment agent may contain the above-mentioned other component (E).

[0082] (solvent) The second treatment agent of the fourth embodiment is mixed with a solvent as necessary to prepare a diluted second treatment agent for polyester staple fiber spunlace (hereinafter also referred to as a diluted second treatment agent). The second treatment agent may be stored or distributed in the form of a diluted second treatment agent. With this configuration, when the second treatment agent is diluted with a solvent or mixed with the first treatment agent at the time of use, the mixability is improved and the stability of the composition is improved. The solvent may be one exemplified in the first embodiment.

[0083] <Actions and Effects of the Fourth Embodiment> In addition to the actions and effects of the above-described embodiments, the fourth embodiment has the following actions and effects.

[0084] (4-1) The second treatment agent of the fourth embodiment contains an organic phosphate ester salt (C) and is used in combination with a first treatment agent containing a fatty acid derivative (A), a fatty acid derivative (B), and optionally a diester (D) during use. This improves the formulation stability and storage stability of the second treatment agent during storage or distribution. In addition, the components of the resulting treatment agent can be adjusted by adjusting the mixing ratio with the first treatment agent. In addition, the second treatment agent alone can be distributed as a separate agent from the first treatment agent.

[0085] <Fifth embodiment> Next, a fifth embodiment of the polyester staple fiber of the present invention will be described. The polyester staple fiber of this embodiment is a treated polyester staple fiber having the treatment agent of the first embodiment adhered to its surface. The treatment agent adheres to the surface of the polyester staple fiber to obtain a modified polyester staple fiber.

[0086] (length of polyester staple fiber) Polyester staple fibers are generally called staple or short cut fibers, and do not include long fibers generally called filaments. Staple fibers are short fibers with a fiber length of 3 cm to 7 cm. Short cut fibers are short fibers with a fiber length of 1 cm or less. In other words, polyester staple fibers refer to short fibers with a fiber length of 7 cm or less.

[0087] As described below, when a spunlace nonwoven fabric is produced using polyester staple fibers, the fibers constituting the nonwoven fabric may contain the above-mentioned long fibers. In other words, the treatment agent of the present invention is not limited to being applied to polyester staple fibers, but may also be applied to long fibers other than polyester staple fibers mixed into the nonwoven fabric.

[0088] (Type of polyester staple fiber) Specific examples of polyester staple fibers include polyethylene terephthalate, polybutylene terephthalate, polyethylene terephthalate-isophthalate, and polyether polyester.

[0089] (Treatment agent attachment treatment) There is no particular restriction on the proportion of the treatment agent of the first embodiment that is applied to the polyester staple fibers. The treatment agent is preferably a solvent-free treatment agent that is applied to the polyester staple fibers in an amount of 0.1% by mass to 2% by mass, and more preferably 0.3% by mass to 1.2% by mass.

[0090] The treatment agent can be applied to the polyester staple fibers by a known method, such as a dipping method, a spray method, a roller method, or a guide oiling method using a metering pump, using the diluted solution of the second embodiment.

[0091] (Nonwoven fabric manufacturing method) The polyester staple fiber of the present embodiment may be used to produce a nonwoven fabric by the following method. Specifically, the nonwoven fabric can be obtained by going through the following steps.

[0092] Step 1: A step of adhering the treatment agent of the first embodiment to polyester staple fibers. Step 2: A step of passing the polyester staple fibers to which the treatment agent has been applied in step 1 through a roller carding machine to obtain a roller carded web. Step 2 is also called a carding step.

[0093] Step 3: A step of obtaining a nonwoven fabric by entangling the fibers with each other by a spunlace method in which a high-pressure water stream is sprayed onto the roller-carded web obtained in step 2. Step 3 is also called a spunlace step.

[0094] By going through the above steps, a nonwoven fabric can be produced. Since the fibers are entangled by the spunlace method, the nonwoven fabric can be called a spunlace nonwoven fabric. In the case of using a two-component type treatment agent in step 1, a diluted solution of the treatment agent containing a solvent such as water, the first treatment agent of the third embodiment, and the second treatment agent of the fourth embodiment is prepared and applied to the polyester staple fibers. The diluted solution can be prepared, for example, by adding the first treatment agent and the second treatment agent to water.

[0095] In the case of using the first and second treatment agents in combination, the mixing ratio of each agent can be changed as desired, so that even under different production conditions such as different production equipment or different climates such as temperature and humidity, it is easy to finely adjust the mixing ratio and prepare a treatment agent or dilution solution to always impart optimal fiber properties or fiber production properties.

[0096] The ratio of the content of the first treatment agent to the second treatment agent is not particularly limited, but the mass ratio of the non-volatile contents of the first treatment agent to the second treatment agent is preferably 95 / 5 to 5 / 95. By specifying the ratio within this range, operability can be improved.

[0097] In order to emulsify the treating agents, each treating agent may be mixed with a solvent and stirred using a known stirrer, such as a homomixer, homogenizer, colloid mill, or line mixer. The diluted solution obtained as described above can be applied to polyester staple fibers in at least one of the steps of the spinning step, the drawing step, and the finishing step of the polyester staple fibers, to obtain polyester staple fibers having a treatment agent attached thereto.

[0098] <Actions and Effects of Fifth Embodiment> In addition to the actions and effects of the above-described embodiments, the fifth embodiment has the following actions and effects.

[0099] (5-1) The polyester staple fiber has the treatment agent of the first embodiment attached thereto. Therefore, the antistatic property and roller card web uniformity of the polyester staple fiber can be improved. The improved antistatic property of the polyester staple fiber improves the processability of the polyester staple fiber in the carding process. Furthermore, the improved roller card web uniformity of the polyester staple fiber reduces the variation in thickness and density in the subsequent spunlace process, making it possible to obtain a nonwoven fabric of better quality. Therefore, the nonwoven fabric produced using the polyester staple fiber of the present invention can be suitably applied to applications such as wet tissues and masks.

[0100] (5-2) In addition, in the case of a multi-dose formulation, the first and second processing agents are added to a solvent immediately before use to prepare the formulation, thereby making it possible to improve the formulation stability and storage stability. EXAMPLES

[0101] In the following, examples will be given to more specifically describe the configuration and effects of the present invention, but the present invention is not limited to these examples. In the following examples and comparative examples, % means % by mass, and parts means parts by mass.

[0102] Test Category 1 (Preparation of treatment agent for polyester staple fiber spunlace) (Example 1-1) 950 g of water was heated to 50° C., and while stirring, 3.5 g of a compound (A-1) in which 3 moles of EO were added to 1 mole of linoleic acid as the fatty acid derivative (A), 16.5 g of a compound (B-1) in which 3 moles of EO were added to 1 mole of oleic acid as the fatty acid derivative (B), 20 g of potassium undecyl phosphate ester salt (C-1) as the organic phosphate ester salt (C), 2 g of polyoxyethylene (mass average molecular weight 200) dioleate (D-1) as the diester (D), and 1 g of polyoxyethylene To the mixture were added 0.5 g of olefin (mass average molecular weight 800) dioleate (D-2), and as other components (E), 1.5 g of a compound (E-1) in which 9 moles of EO and 9 moles of PO are randomly added to 1 mole of castor oil, 5 g of a compound (E-2) in which 7 moles of EO and 3 moles of PO are randomly added to 1 mole of castor oil, and 1 g of a compound (E-3) in which 5 moles of EO and 5 moles of PO are randomly added to 1 mole of hydrogenated castor oil, and mixed to obtain a 5 mass % aqueous solution of the treatment agent for polyester staple fiber spunlace of Example 1.

[0103] (Examples 1-2 to 1-20, Comparative Examples 1 to 5) Each of the treating agents in Examples 1-2 to 1-20 and Comparative Examples 1 to 5 was prepared in the same manner as in Example 1 using the components shown in Table 1.

[0104] The type and content of fatty acid derivative (A), the type and content of fatty acid derivative (B), the type and content of organic phosphate ester salt (C), the type and content of diester (D), the type and content of other component (E), and the mass ratio of fatty acid derivative (A) to fatty acid derivative (B) in each example of the treatment agent are as shown in the "Fatty acid derivative (A)" column, the "Fatty acid derivative (B)" column, the "Organic phosphate ester salt (C)" column, the "Diester (D)" column, the "Other components (E)" column, and the "Am / Bm" column in Table 1, respectively.

[0105] [Table 1]

[0106] Details of the fatty acid derivative (A), fatty acid derivative (B), organic phosphate ester salt (C), diester (D), and other component (E) listed in Table 1 are as follows. <Fatty acid derivative (A)> As the fatty acid derivatives (A), A-1 to A-5 shown in Table 2 below were used.

[0107] The type of fatty acid derivative (A) and the mass proportion of the oxyalkylene group in the molecular structure are shown in Table 2 in the columns "Type of fatty acid derivative (A)" and "Mass proportion of oxyalkylene group", respectively.

[0108] [Table 2]

[0109] <Fatty acid derivative (B)> As the fatty acid derivatives (B), B-1 to B-5 shown in Table 3 below were used. The type of fatty acid derivative (B) and the mass proportion of the oxyalkylene group in the molecular structure are shown in Table 3 in the columns "Type of fatty acid derivative (B)" and "Mass proportion of oxyalkylene group", respectively.

[0110] [Table 3]

[0111] <Organophosphate ester salts (C)> As the organic phosphate ester salts (C), C-1 to C-6 shown in Table 4 below were used. The alkyl group linearity ratio, alkyl group carbon number, acid value, and P nuclear NMR integral ratio of the organic phosphate salt (C) are shown in the "Alkyl group linearity ratio", "Alkyl group carbon number", "Acid value", and "P nuclear NMR integral ratio" columns in Table 4. In Table 4, "mono-form", "di-form", and "poly-form" respectively mean "monoester form", "diester form", and "diphosphate form". The P nuclear NMR integral ratio can be measured by a known method.

[0112] [Table 4]

[0113] <Diester (D)> D-1: Polyoxyethylene (mass average molecular weight 200) dioleate D-2: Polyoxyethylene (mass average molecular weight 800) dioleate D-3: Polyoxyethylene (mass average molecular weight 400) dilaurate D-4: Polyoxyethylene (mass average molecular weight 600) dilaurate <Other ingredients (E)> E-1: A compound in which 9 moles of EO and 9 moles of PO are randomly added to 1 mole of castor oil. E-2: A compound in which 7 moles of EO and 3 moles of PO are randomly added to 1 mole of castor oil. E-3: A compound in which 5 moles of EO and 5 moles of PO are randomly added to 1 mole of hydrogenated castor oil. E-4: A compound in which 9 moles of EO and 9 moles of PO are randomly added to 1 mole of hydrogenated castor oil. E-5: Sodium salt of secondary alkanesulfonic acid having 11 to 14 carbon atoms E-6: Lauryl alcohol E-7: Oleic acid E-8: Potassium octanoate E-9: An ester compound obtained by dehydration condensation of 0.1 mol of polyoxyethylene polyoxypropylene glycol (random polymer: mass average molecular weight 13,000, EO component ratio 75% by mass), 0.5 mol of polyethylene glycol (mass average molecular weight 600), and 0.4 mol of polyethylene glycol (mass average molecular weight 400) per 1 mol of sebacic acid. E-10: Propylene glycol E-11: Ethylene glycol monobutyl ether phosphate potassium salt E-12: Polyoxyethylene (mass average molecular weight 400) monolaurate Test section 2 (Preparation of polyester staple fiber treated cotton) A 5% by mass aqueous solution of the polyester staple fiber spunlace treatment agent prepared in Test Section 1 was applied to polyester staple fibers (fineness 1.5 dtex, fiber length 38 mm) by spray oiling so that the amount of non-volatile matter of the treatment agent attached to the polyester staple fibers was 0.14% by mass. The raw cotton to which the treatment agent was applied was then dried for 2 hours in a hot air dryer at 80°C, and then conditioned overnight in an atmosphere at 25°C and 40% RH. The conditioned cotton was used as polyester staple fiber treated cotton (hereinafter also referred to as treated cotton).

[0114] Test category 3 (antistatic) 5 g of the treated cotton was conditioned for 24 hours in a thermostatic chamber at 20°C and 45% RH, and then the electrical resistance (Ω) was measured using an electrical resistance meter (SM-5E model, manufactured by Toa Denpa Kogyo Co., Ltd.) and evaluated according to the following criteria. The results are shown in the "Antistatic property" column of Table 1.

[0115] Evaluation criteria for antistatic properties 3 (Good): Surface resistance is 1.0 x 10 9 Less than Ω 2 (OK): Surface resistance is 1.0 x 10 9 Ω or more 1.0×10 10 Less than Ω 1 (not acceptable): Surface resistance is 1.0 x 10 10 Ω or more Test Section 4 (Roller Card Web Uniformity) 20 g of the treated cotton was conditioned for 24 hours in a thermostatic chamber at 20°C and 65% RH, and then subjected to a known roller carding machine. The texture of the discharged roller carded web was visually evaluated according to the following criteria. The results are shown in the "Web uniformity" column of Table 1.

[0116] Roller card web uniformity evaluation criteria 4 (Excellent): The roller card web has no disturbance in its formation and has a very good appearance.

[0117] 3 (good): The roller card web has little disturbance in its texture and has a good appearance. 2 (Fair): There is some disruption in the texture of the roller card web. 1 (Unacceptable): Disorders in the roller card web are observed.

[0118] Test category 5 (anti-foaming) 15 g of the treated cotton was placed in 150 g of water, and after 2 hours, the treated cotton was squeezed using a known hand juicer. 10 g of the squeezed liquid was placed in a 25 mL graduated cylinder with a stopper and vigorously shaken for 30 seconds. After leaving it to stand for 5 minutes, the height from the water surface to the top of the foam was measured and evaluated according to the following evaluation criteria. The results are shown in the "Foam suppression" column in Table 1.

[0119] ·Evaluation criteria for foam suppression 3 (Good): Foaming less than 3 mm 2 (Acceptable): Foam is 3mm or more but less than 10mm 1 (Not acceptable): Foam is 10mm or more Test category 6 (hydrophilicity) 5 g of the treated cotton was placed in a 3 g metal basket and placed in 1 L of water. The time it took for the treated cotton to be completely immersed in water was measured and evaluated according to the following criteria. The results are shown in the "hydrophilicity" column in Table 1.

[0120] Evaluation criteria for hydrophilicity 3 (Good): Complete immersion in water for less than 5 seconds 2 (Acceptable): Time until completely immersed in water is between 5 and 10 seconds 1 (Not acceptable): Complete immersion in water for 10 seconds or more Test category 7 (emulsion stability) 20 g of a 5% by mass aqueous solution of each treatment agent was placed in a test tube with a diameter of 18 mm and allowed to stand in a thermostatic chamber at 20° C. After 24 hours, the condition of the aqueous solution was visually observed and evaluated according to the following criteria. The results are shown in the "Emulsion stability" column in Table 1.

[0121] ·Evaluation criteria for emulsion stability 3 (Good): There is no precipitation or separation, and the mixture is in a uniform state. 2 (Fair): No precipitation is observed, but separation has occurred.

[0122] 1 (Fail): Precipitation has occurred and the mixture is inhomogeneous. Test section 8 (Preparation of diluted solution of first treatment agent of two-agent type treatment agent) (First treatment agent dilution (I-1) to (I-20)) Each component was weighed out so as to obtain the content ratio shown in Table 5, and the components were stirred and mixed to prepare diluted first treatment agent solutions for polyester staple fiber spunlace (diluted first treatment agent solutions (I-1) to (I-20)).

[0123] The types and contents of fatty acid derivatives (A), fatty acid derivatives (B), diesters (D), other components (E), and water contents in the first treatment agent diluted solutions (I-1) to (I-20) are as shown in the "Fatty acid derivatives (A)", "Fatty acid derivatives (B)", "Diesters (D)", "Other components (E)", and "Solvent" columns in Table 5, respectively.

[0124] [Table 5]

[0125] Test section 9 (Preparation of diluted solution of the second treatment agent of two-agent treatment agent) Each component was weighed out so as to obtain the content ratio shown in Table 6, and the components were stirred and mixed to prepare diluted second treatment agent solutions for polyester staple fiber spunlace (diluted second treatment agent solutions (II-1) to (II-6)).

[0126] The type and content of the organic phosphate ester salt (C) and the water content in the second treatment agent diluted solutions (II-1) to (II-6) are as shown in the "Organic phosphate ester salt (C)" and "Solvent" columns of Table 6, respectively.

[0127] [Table 6]

[0128] Test section 10 (Evaluation of formulation stability of diluted first treatment agent and diluted second treatment agent) 10 mL of the first and second treatment diluted solutions prepared for each example was placed in a test tube and visually observed to determine the stability according to the following criteria. The results are shown in the "Formulation stability" column of Tables 5 and 6.

[0129] -Evaluation criteria for formulation stability 2 (Acceptable): If there is no separation or precipitate immediately after preparation 1 (Not acceptable): If separation or precipitation is observed immediately after preparation Test section 11 (Preparation of diluted treatment solution from diluted first treatment solution and diluted second treatment solution) (Example 2-1) The second diluted treatment agent solution (II-1) shown in Table 6 was added to half the prescribed amount of water heated to about 50°C under stirring until completely dissolved. After dissolution, the first diluted treatment agent solution (I-1) shown in Table 5 was added under stirring until completely dissolved. After dissolution, heating was stopped, and the remaining half of the water at about 25°C was added all at once and stirred until uniform, to obtain a 5 mass% aqueous solution of the diluted treatment agent solution of Example 2-1.

[0130] (Examples 2-2 to 2-20) In the same manner as in Example 2-1, the first diluted treatment agent solution shown in Table 5 and the second diluted treatment agent solution shown in Table 6 were mixed to prepare diluted treatment agent solutions of each example.

[0131] The type and content of the first diluted treatment agent and the type and content of the second diluted treatment agent are shown in Table 7 in the "First diluted treatment agent" and "Second diluted treatment agent" columns, respectively.

[0132] [Table 7]

[0133] Test category 12 (Evaluation of diluted solutions of two-component treatment agents) The obtained diluted solutions of the treatment agents of each of the examples such as Example 2-1 were evaluated for antistatic properties, roller card web uniformity, antifoaming properties, hydrophilicity, and emulsion stability in the same manner as for the treatment agent of Example 1-1. The results are shown in the "Antistatic properties", "Web uniformity", "Antifoam properties", "Hydrophilicity", and "Emulsion stability" columns of Table 7.

[0134] From the results in the above table, it can be seen that the present invention can improve the antistatic properties, roller card web uniformity, foam suppression, and hydrophilicity of the fibers to which the treatment agent is applied, and can also improve the emulsion stability of the diluted treatment agent solution.

Claims

1. A treatment agent for polyester staple fiber spunlace, comprising the following fatty acid derivative (A), the following fatty acid derivative (B), and an organic phosphoric acid ester salt (C): The non-volatile content of the treatment agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25 mass% or more and 90 mass% or less, and the organic phosphate ester salt (C) in a proportion of 5 mass% or more and 65 mass% or less. Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): an alkylene oxide adduct of at least one selected from oleic acid and stearic acid.

2. 2. The treating agent for polyester staple fiber spunlace according to claim 1, wherein the mass ratio of oxyalkylene groups in the molecular structures of the fatty acid derivative (A) and the fatty acid derivative (B) is 50 mass % or less, respectively.

3. The treatment agent for polyester staple fiber spunlace according to claim 1, wherein the mass ratio Am / Bm is 0.01 or more and 0.4 or less, where Am is the mass of the fatty acid derivative (A) in the treatment agent for polyester staple fiber spunlace and Bm is the mass of the fatty acid derivative (B).

4. 2. The treatment agent for polyester staple fiber spunlace according to claim 1, wherein the organic phosphate ester salt (C) is a salt of a phosphate ester having an alkyl group having 11 to 13 carbon atoms.

5. The treatment agent for polyester staple fiber spunlace according to claim 1, wherein the non-volatile content of the treatment agent for polyester staple fiber spunlace is 30% by mass or more and 70% by mass or less of the fatty acid derivative (A) and the fatty acid derivative (B), and 10% by mass or more and 60% by mass or less of the organic phosphate ester salt (C).

6. 2. The treating agent for polyester staple fiber spunlace according to claim 1, further comprising the following diester (D): Diester (D): A diester of polyethylene glycol having a molecular weight of 200 or more and 800 or less and a monovalent fatty acid having 12 or more and 20 or less carbon atoms.

7. The treatment agent for polyester staple fiber spunlace according to claim 6, wherein the non-volatile content of the treatment agent for polyester staple fiber spunlace is 30% by mass or more and 70% by mass or less of the fatty acid derivative (A) and the fatty acid derivative (B), 10% by mass or more and 60% by mass or less of the organic phosphate ester salt (C), and 2% by mass or more and 10% by mass or less of the diester (D).

8. A diluted solution of a treatment agent for polyester staple fiber spunlace, comprising the treatment agent for polyester staple fiber spunlace according to any one of claims 1 to 7, and water.

9. A first treating agent for polyester staple fiber spunlace, which is used in combination with a second treating agent for polyester staple fiber spunlace containing an organic phosphoric acid ester salt (C), comprising: A first treatment agent for polyester staple fiber spunlace, comprising the following fatty acid derivative (A), the following fatty acid derivative (B), and optionally the following diester (D), and is used in combination with the second treatment agent for polyester staple fiber spunlace so that the non-volatile content of the treatment agent for polyester staple fiber spunlace mixed with the second treatment agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25% by mass or more and 90% by mass or less, and the organic phosphate ester salt (C) in a ratio of 5% by mass or more and 65% by mass or less. Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): an alkylene oxide adduct of at least one acid selected from oleic acid and stearic acid. Diester (D): A diester of polyethylene glycol having a molecular weight of 200 or more and 800 or less and a monovalent fatty acid having 12 or more and 20 or less carbon atoms.

10. A second treatment agent for polyester staple fiber spunlace, which is used in combination with a first treatment agent for polyester staple fiber spunlace, comprising the following fatty acid derivative (A), the following fatty acid derivative (B), and optionally the following diester (D): A second treatment agent for polyester staple fiber spunlace, which contains an organic phosphate ester salt (C) and is used in combination with the first treatment agent for polyester staple fiber spunlace so that the non-volatile content of the treatment agent for polyester staple fiber spunlace mixed with the first treatment agent for polyester staple fiber spunlace contains the fatty acid derivative (A) and the fatty acid derivative (B) in a total amount of 25% by mass or more and 90% by mass or less, and the organic phosphate ester salt (C) in a ratio of 5% by mass or more and 65% by mass or less. Fatty acid derivative (A): at least one alkylene oxide adduct selected from linoleic acid and linolenic acid. Fatty acid derivative (B): an alkylene oxide adduct of at least one selected from oleic acid and stearic acid. Diester (D): A diester of polyethylene glycol having a molecular weight of 200 to 800 and a monovalent fatty acid having 12 to 20 carbon atoms.

11. A polyester staple fiber having the treating agent for polyester staple fiber spunlace according to any one of claims 1 to 7 adhered thereto.

Citation Information

Patent Citations

  • Synthetic fiber treatment agent and use of the same

    JP2015145545A

  • Fiber treatment agent

    JP4139130B2

  • Treatment agents for nonwoven fabric manufacturing and their uses

    JP6605833B2

  • Fiber-treating agent, short polyester fiber made with the same, and nonwoven fabric

    WO2005098124A1

  • Fiber treatment agent and application thereof

    WO2007108206A1

Cited By

  • JPWO2025115728A1